Sign in or Register

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >

Diagnostic Support

Creative Biolabs provides our clients with a wide range of antibodies which are high quantity and quality for diagnostic support, such as infectious disease, cardiac & cholesterol markers, hormones & fertility, autoimmune disease, drug abuse, pesticides & toxin and so on.

Monoclonal antibodies have tremendous applications. They are widely used in the field of diagnostics, therapeutics and targeted drug delivery system. They are used for infectious diseases caused by bacteria, viruses and protozoa and also for cancer, metabolic and hormonal disorders. In addition, they are utilized in the diagnosis of lymphoid and myeloid malignancies, tissue typing, enzyme-linked immunosorbent assay (ELISA), radio immunoassay, serotyping of microorganisms. Moreover, they are associated with anti-idiotype inhibition, immunological intervention with the passive antibody, or magic bullet therapy with cytotoxic agents coupled with the anti-mouse specific antibody.